Clinical Trial Update: Botulinum Toxin Type A in Treatment of Cranial Allodynia in Patients With Headache [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating botulinum toxin type A for cranial allodynia in patients with headache has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cranial Allodynia
• Headache

Drugs mentioned

• Botulinum toxin type A (botulinum toxin type A)

Snippet

Sponsor: Federal University of Bahia | Conditions: Headache, Allodynia | Phase 3 | Status: COMPLETED